Search

everythinglearnresearchcommunity

for

Search:↓

Autoimmune diseases with high tissue recovery often relapse and remit, while those with low recovery rarely remit.

Alopecia Areata causes hair loss and needs treatments that address both physical and emotional health.

Different stem cells are key for hair growth and health, and understanding their regulation could help treat hair loss.

The guidelines suggest using various treatments, including antidepressants and steroids, for alopecia areata and discuss the condition's genetic and immune aspects.

Metformin, usually used for diabetes, can also help treat hair loss from alopecia areata due to its ability to reduce inflammation and stimulate new hair growth.

Cannabinoids may help treat various skin conditions.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

T-regulatory cells are important for skin health and can affect hair growth and reduce skin inflammation.

Understanding hair growth involves complex factors, and more research is needed to improve treatments for hair loss conditions.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Baricitinib successfully regrew hair in an 8-year-old boy with alopecia totalis linked to a KRT74 gene variant.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

Glycans play a crucial role in regulating hair growth and follicle balance.

Glycans play a crucial role in regulating hair growth and follicle balance.

Alopecia Areata affects people of all ages worldwide, is likely caused by genetic and environmental factors, and can lead to stress and depression, highlighting the need for treatments that address both physical and mental health.

Personalized treatments for hair loss focus on specific genetic and biological pathways.

COVID-19 reinfection may trigger alopecia areata.

Understanding T cells and signaling pathways can lead to better treatments for hair loss.

Immune cells and plasma proteins are linked to hair loss, suggesting new treatment options.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

The paper concludes that the patchiness of alopecia areata is likely due to when the immune attack happens in the hair growth cycle.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

Understanding how hair follicle stem cells work can help find new ways to prevent hair loss and promote hair growth.

Alopecia areata involves immune response and gene changes affecting hair loss.

The research suggests immune system changes and specific gene expression may contribute to male hair loss, proposing potential new treatments.

Alopecia areata causes patchy hair loss and involves immune system disruptions.

Balancing gut bacteria may help prevent and treat certain types of hair loss.